These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34082135)

  • 1. Computational insights into the known inhibitors of human soluble epoxide hydrolase.
    Bzówka M; Mitusińska K; Hopko K; Góra A
    Drug Discov Today; 2021 Aug; 26(8):1914-1921. PubMed ID: 34082135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain.
    Abis G; Charles RL; Eaton P; Conte MR
    Protein Expr Purif; 2019 Jan; 153():105-113. PubMed ID: 30218745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multimodal disease modifying approach to treat neuropathic pain--inhibition of soluble epoxide hydrolase (sEH).
    Pillarisetti S; Khanna I
    Drug Discov Today; 2015 Nov; 20(11):1382-90. PubMed ID: 26259523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.
    Nishi K; Kim IH; Ma SJ
    Protein Expr Purif; 2010 Jan; 69(1):34-8. PubMed ID: 19782755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
    Pallàs M; Vázquez S; Sanfeliu C; Galdeano C; Griñán-Ferré C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32369955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
    Revermann M
    Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Regulation of the Soluble Epoxide Hydrolase by Nitro Fatty Acids: a Combined Experimental and Computational Approach.
    Qiu Q; Abis G; Mattingly-Peck F; Lynham S; Fraternali F; Conte MR
    J Mol Biol; 2022 Sep; 434(17):167600. PubMed ID: 35460669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
    Fang X
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
    Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
    Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase inhibitors and cardiovascular diseases.
    Wang ZH; Davis BB; Jiang DQ; Zhao TT; Xu DY
    Curr Vasc Pharmacol; 2013 Jan; 11(1):105-11. PubMed ID: 22303912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxyeicosanoids in hypertension.
    Imig JD
    Physiol Res; 2019 Oct; 68(5):695-704. PubMed ID: 31475560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
    Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
    J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
    Sanders WG; Morisseau C; Hammock BD; Cheung AK; Terry CM
    Am J Physiol Cell Physiol; 2012 Aug; 303(3):C278-90. PubMed ID: 22621785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
    Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.